This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Set to Soar Higher

Rosetta Genomics

An under-$10 stock in the biotechnology and drugs complex that's setting up to trigger a major breakout trade is Rosetta Genomics (ROSG), which develops and commercializes diagnostic tests based on microRNAs. This stock has been on fire so far in 2012, with shares up a whopping 170%.

>>4 Biotech Stocks Under $10 Soaring Higher

If you take a look at the chart for Rosetta Genomics, you'll see that this stock recently spiked back above both its 50-day and 200-day moving averages with above-average volume. This move has also pushed ROSG back above some near-term overhead resistance at $6.87 to $7.19 a share with decent volume. Now ROSG is flirting with some more overhead resistance at $7.56 a share, which is quickly pushing the stock into breakout territory.

Market players should now look for long-biased trades in ROSG as long as it's trending above those overhead resistance levels at $7.19 to $7.56 a share with strong upside volume flows. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 1.7 million shares. If ROSG can maintain that trend, then this stock has a great chance of trending higher back towards its next significant overhead resistance levels at $11.47 to $12.87 a share.

Traders can now look to buy ROSG off any weakness and simply use a stop that sits just below some near-term support at $6.90 a share. One could also buy ROSG off strength as long as it's rending above $7.19 with strong upside volume flows. Keep in mind that ROSG has hit an intraday high today of $7.73 a share, so that is another reference point that breakout traders should watch.
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
MPO $0.25 -11.35%
POZN $5.65 -5.04%
APPY $0.24 0.00%
FALC $1.70 0.00%
ROSG $0.81 0.00%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs